Patent · US Active

Fusion proteins comprising an engineered knottin peptide and uses thereof

US10844106B2 · kind B2 · utility

1Cited by
7References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2011
Grant dateNov 24, 2020
Priority date
Expiry dateJun 19, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure presents a general approach to engineering existing protein-protein interactions through domain addition and evolution. The disclosure teaches the creation of novel fusion proteins that include knottin peptides where a portion of the knottin peptide is replaced with a sequence that has been created for binding to a particular target. Such fusion proteins can also be bispecific or multi specific in that they can bind to and/or inhibit two or more receptors or receptor ligands. Knottins may be fused with an existing ligand (or receptor) as a general platform for increasing the affinity of a ligand-receptor interaction or for creating a multi specific protein. In addition, the fusion proteins may comprise a knottin peptide fused to another protein where the other protein facilitates proper expression and folding of the knottin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.